will fda ban compounded semaglutide announces for weight loss drugs Novo Nordisk's semaglutide shortage officially

Check for accreditation by the National Association of Boards of Pharmacy (NABP) or verify that it is listed as an FDA-registered outsourcing facility

And then the questions start rolling in

Clinical research has evaluated doses up to 12 mg per week, depending on individual tolerance and treatment goals

Sources Phase 2 trial (NEJM) New England Journal of Medicine TRIUMPH-4 results Eli Lilly Investor Relations JAMA coverage of Phase 2 results JAMA Related reading Retatrutide Phase 3 Trials 2026: TRIUMPH & TRANSCEND-T2D Tracker Living tracker of every retatrutide trial TRIUMPH-1/3/4/5, TRIUMPH-Outcomes, TRANSCEND-T2D-1/2, and SYNERGY-OUTCOMES Phase 3 readouts